subject: The Real Cost of Breast Enlargement Surgery [print this page] For years, women have suffered the agony of small, underdeveloped, or sagging bosom. For many women, the answer has been the very costly and dangerous cosmetic surgery instead of natural ways.
But the cost and risks make this an undesirable option. The average cost of a breast enhancement surgery is between $5,000 and $6,000. Most people simply don't have this kind of money to spend on breast enlargement surgery!
Breast enlargement surgery, according to the American Society of Plastic Surgeons (ASPS), was the fourth most popular invasive surgical procedure among cosmetic plastic surgeries performed in 2000. In a press release dated July 12, 2001, the ASPS says that breast augmentation was performed on 212,500 women last year.
Meanwhile, millions of women have been subjected to the ill effects of these modern day vanity contraptions that were bought in good faith.
Silicone gel implants were banned in 1992 by FDA.
Depending on your health insurance provider, if you have (or had) a ruptured silicone breast implant, you will most likely be denied Health Insurance Coverage.
Saline-filled implants tend to have a higher rate of leaking and deflation than silicone gel implants, which means more frequent surgery to replace them.
In a study published in the Lancet medical journal, Dr Lori Brown of the Food and Drug Administration (FDA) says: "There is emerging consensus that both the incidence and prevalence of breast-implant rupture are much higher than previously suspected.
21% overall increase in cancers for women with implants, compared to women of the same age in the general population.
Implant patients were three times as likely to die from lung cancer, emphysema and pneumonia as other plastic surgery patients.The study is based on medical records and death certificates of almost 8,000 women with breast implants, including silicone gel implants and saline implants, and more than 2,000 other plastic surgery patients. ( National Cancer Institute (NCI), Boston University, Abt Associates, and the Food and Drug Administration, with Dr. Louise Brinton from NCI as lead author. )
